Registered entities
Jounce Therapeutics, Inc.
Reg. No. 454870634United States
Innovation
22 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 4,622 times.
| Year | Filings |
|---|---|
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 10 |
| 2021 | 12 |
| 2022 | 12 |
| 2023 | 8 |
| 2024 | 5 |
| 2025 | 1 |
Investor mix
11 investors on record; lead investors include Celgene; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 55% |
| Private equity | 1 | 9% |
| Other / undisclosed | 4 | 36% |